S. Emami

410 total citations
27 papers, 349 citations indexed

About

S. Emami is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, S. Emami has authored 27 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 6 papers in Genetics. Recurrent topics in S. Emami's work include Neuropeptides and Animal Physiology (9 papers), Mast cells and histamine (4 papers) and Diabetes Treatment and Management (4 papers). S. Emami is often cited by papers focused on Neuropeptides and Animal Physiology (9 papers), Mast cells and histamine (4 papers) and Diabetes Treatment and Management (4 papers). S. Emami collaborates with scholars based in France, Belgium and Iran. S. Emami's co-authors include Christian Gespach, Ali Mohammad Sharifi, Eric Chastre, G Rosselin, Lluis M. Mir, Abolfazl Akbari, Shahram Agah, Dominique Fagot, Wafaa Bawab and Dominique Bondoux and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Oncogene.

In The Last Decade

S. Emami

27 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Emami France 10 183 93 74 53 48 27 349
Tomoko Nashida Japan 15 348 1.9× 94 1.0× 58 0.8× 42 0.8× 31 0.6× 45 638
Marc Giry-Laterrière Australia 11 243 1.3× 94 1.0× 31 0.4× 89 1.7× 53 1.1× 14 452
Isabel Mayo Spain 12 213 1.2× 38 0.4× 83 1.1× 32 0.6× 14 0.3× 14 482
Loïc Van Den Berghe France 13 275 1.5× 80 0.9× 54 0.7× 30 0.6× 42 0.9× 21 461
Christopher M. Cox United States 7 292 1.6× 64 0.7× 80 1.1× 17 0.3× 19 0.4× 11 424
Jane L. Ko United States 15 420 2.3× 59 0.6× 269 3.6× 62 1.2× 39 0.8× 20 599
Marı́a Francisca Arteaga Germany 15 401 2.2× 42 0.5× 38 0.5× 53 1.0× 52 1.1× 25 558
Emily K. Blue United States 12 343 1.9× 37 0.4× 30 0.4× 40 0.8× 49 1.0× 19 497
Yunyun Jin China 12 251 1.4× 38 0.4× 45 0.6× 92 1.7× 38 0.8× 16 476
Eileen Sweezer United States 5 363 2.0× 35 0.4× 36 0.5× 61 1.2× 42 0.9× 8 443

Countries citing papers authored by S. Emami

Since Specialization
Citations

This map shows the geographic impact of S. Emami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Emami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Emami more than expected).

Fields of papers citing papers by S. Emami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Emami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Emami. The network helps show where S. Emami may publish in the future.

Co-authorship network of co-authors of S. Emami

This figure shows the co-authorship network connecting the top 25 collaborators of S. Emami. A scholar is included among the top collaborators of S. Emami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Emami. S. Emami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Emami, S., et al.. (2018). Evaluation of circulating miR-21 and miR-222 as diagnostic biomarkers for gastric cancer. Journal of Cancer Research and Therapeutics. 15(1). 115–115. 41 indexed citations
2.
Emami, S., et al.. (2012). Differentiation of human adipose-derived mesenchymal stem cell into insulin-producing cells: an in vitro study. Journal of Physiology and Biochemistry. 69(3). 451–458. 56 indexed citations
3.
Emami, S.. (2010). Interplay between p53-family, their regulators, and PARPs in DNA repair. Clinics and Research in Hepatology and Gastroenterology. 35(2). 98–104. 9 indexed citations
4.
Rodrigues, Sylvie, Christelle M. Rodrigue, Samir Attoub, et al.. (2006). Induction of the adenoma-carcinoma progression and Cdc25A-B phosphatases by the trefoil factor TFF1 in human colon epithelial cells. Oncogene. 25(50). 6628–6636. 30 indexed citations
5.
Emami, S.. (2004). Trefoil factor family (TFF) peptides and cancer progression. Peptides. 8 indexed citations
6.
Wakkach, A., Eric Chastre, Corine Bruand, et al.. (2001). Phenotypic and functional characterization of human thymic stromal cell lines.. PubMed. 47(1). 167–78. 9 indexed citations
7.
Boissard, Claudine, et al.. (2000). Decreased ADP-Ribosylation of the Gαolf and Gαs Subunits by High Glucose in Pancreatic B-Cells. Biochemical and Biophysical Research Communications. 271(1). 86–90. 7 indexed citations
8.
Emami, S., Marcia Pessah, Claudine Boissard, et al.. (1997). Molecular diversity of the adenylyl cyclase-coupled signaling in pancreatic islet cells. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 1 indexed citations
9.
Launay, Jean‐Marie, Dominique Bondoux, María Jesús Oset‐Gasque, et al.. (1994). Increase of human platelet serotonin uptake by atypical histamine receptors. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 266(2). R526–R536. 37 indexed citations
10.
Chastre, Eric, S. Emami, & Christian Gespach. (1991). Immortalisation et transformation tumorale de l'épithélium gastro-intestinal chez l'homme et le rat : applications en cancérologie et dans la mucoviscidose. médecine/sciences. 7(4). R17–R17. 1 indexed citations
11.
12.
Lévy, Patrick, et al.. (1990). Altered expression of proteoglycans in E1A-immortalized rat fetal intestinal epithelial cells in culture.. PubMed. 50(20). 6716–22. 9 indexed citations
13.
Gespach, Christian, Dominique Fagot, & S. Emami. (1989). Pharmacological control of the human gastric histamine H2 receptor by famotidine: comparison with H1, H2 and H3 receptor agonists and antagonists. European Journal of Clinical Investigation. 19(1). 1–10. 11 indexed citations
14.
Emami, S., Lluis M. Mir, Christian Gespach, & G Rosselin. (1989). Transfection of fetal rat intestinal epithelial cells by viral oncogenes: establishment and characterization of the E1A-immortalized SLC-11 cell line.. Proceedings of the National Academy of Sciences. 86(9). 3194–3198. 36 indexed citations
15.
Fagot, Dominique, S. Emami, Eric Chastre, Wafaa Bawab, & Christian Gespach. (1988). Pharmacological control of the histamine H2 receptor-adenylate cyclase system by famotidine and ranitidine in normal and cancerous human gastric epithelia. Inflammation Research. 23(3-4). 293–296. 9 indexed citations
16.
Emami, S., Lluis M. Mir, Eric Chastre, et al.. (1988). Expression of histamine and vasoactive intestinal peptide (VIP) receptors in immortalized rat fetal intestinal cells. Inflammation Research. 23(3-4). 276–279. 4 indexed citations
17.
Gespach, Christian, Wafaa Bawab, Eric Chastre, et al.. (1988). Pharmacology and molecular identification of vasoactive intestinal peptide (VIP) receptors in normal and cancerous gastric mucosa in man. Biochemical and Biophysical Research Communications. 151(2). 939–947. 13 indexed citations
18.
Hervatin, Florence, et al.. (1987). Effect of a milk diet on rat gastric mucosa: Receptor activity, histamine metabolism and ultrastructural analyses. Inflammation Research. 20(3-4). 265–269. 3 indexed citations
19.
Emami, S., Eric Chastre, N Mulliez, M. Gonzalés, & Christian Gespach. (1986). VIP and histamine H2 receptor activity in human fetal gastric glands. Cellular and Molecular Life Sciences. 42(4). 423–425. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomoko Nashida Breakdown of academic impact, for papers by Marc Giry-Laterrière Breakdown of academic impact, for papers by Isabel Mayo Breakdown of academic impact, for papers by Loïc Van Den Berghe Breakdown of academic impact, for papers by Christopher M. Cox Breakdown of academic impact, for papers by Jane L. Ko Breakdown of academic impact, for papers by Marı́a Francisca Arteaga Breakdown of academic impact, for papers by Emily K. Blue Breakdown of academic impact, for papers by Yunyun Jin Breakdown of academic impact, for papers by Eileen Sweezer
Rankless by CCL
2026